119th Congress
H.R. 1620
Finn Sawyer Access to Cancer Testing Act
- Introduced
- In committee
- Passed House
- Passed Senate
- To President
- Became law
- Sponsor
- Doris O. Matsui(D-CA)
- Introduced
- Feb 26, 2025
- Policy area
- Health
- Committees
- House Committee on Energy and Commerce; House Committee on Ways and Means
- Official text
- Introduced in House · Congress.gov page
Cosponsors (13)
Original cosponsors (10)
- Debbie Wasserman Schultz (D-FL)
- Donald G. Davis (D-NC)
- Don Bacon (R-NE)
- Greg Landsman (D-OH)
- Gus M. Bilirakis (R-FL)
- James A. Himes (D-CT)
- Mike Thompson (D-CA)
- Rashida Tlaib (D-MI)
- Terri A. Sewell (D-AL)
- G000551
Added later (3)
- Josh Gottheimer (D-NJ) · May 21, 2025
- Paul Tonko (D-NY) · Nov 7, 2025
- Chellie Pingree (D-ME) · Nov 10, 2025
Summary
Summary by the Congressional Research Service· describes the “Introduced in House” version
Finn Sawyer Access to Cancer Testing Act
This bill provides for coverage of certain cancer diagnostic and laboratory tests under Medicare, Medicaid, and the Children's Health Insurance Program (CHIP). Specifically, the bill provides for coverage of microarray analysis, DNA and RNA sequencing, whole-exome sequencing, and other next-generation sequencing for individuals diagnosed with cancer.
Additionally, the Department of Health and Human Services must establish an education and awareness program for physicians and the public about genomic testing and the role of genetic counselors.
Roll-call votes
No recorded votes on this bill.
Actions
- Feb 26, 2025 · House
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. - Feb 26, 2025
Introduced in House